The apnea-hypopnea index (AHI) is a scale that tells whether you have a sleep disorder called apnea and, if so, how serious it is. Sleep apnea is when you stop breathing for 10 seconds or more ...

Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. | Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. The ...

AD109 is a once daily pill that consists of aroxybutynin, an antimuscarinic, and atomoxetine, a selective norepinephrine reuptake inhibitor.

AD109 met the primary endpoint, mean change in apnea-hypopnea index (AHI, p=0.001) at 26 weeks, across a broad range of people with mild, moderate and severe obstructive sleep apnea Study ...

Frontoparietal cerebrovascular pathology is linked to oxygenation during REM sleep, indicating possible connection to Alzheimer Disease.

The main goal was to measure at six months the change in the apnea-hypopnea index, a scale used to measure the breathing reductions or interruptions during sleep (the higher the score, the more ...

Two randomized controlled trials show reduction in AHI; significant improvements seen in all secondary end points. (HealthDay News) — Tirzepatide reduces the apnea-hypopnea index (AHI) among ...

Researchers used this home sleep study data to determine each person’s apnea-hypopnea index, the number of times per hour that breathing stops or is reduced. Researchers then compared how well ...

Use of a modified sleep apnea index can identify cardiovascular risk factors in adults with moderate to severe obstructive sleep apnea (OSA), according to results from a new study presented at the ...